4
Changes in Ownership
Kiniksa Pharmaceuticals International, plc Filed Acc 0001415889-25-014744
CHAIRMAN & CEO sold 86,270 shares at an average $27.24 ($2,349,981)
- CHAIRMAN & CEO acquired 86,270 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Patel Sanj K CHAIRMAN & CEO | 2025-05-23 | Option exercise 10b5-1 | +4,837 | $1.59 | $7,691 | 101,511 | D |
| Patel Sanj K CHAIRMAN & CEO | 2025-05-23 | Sale 10b5-1 | −4,837 | $27.00 | $130,599 | 96,674 | D |
| Patel Sanj K CHAIRMAN & CEO | 2025-05-27 | Option exercise 10b5-1 | +19,317 | $1.59 | $30,714 | 115,991 | D |
| Patel Sanj K CHAIRMAN & CEO | 2025-05-27 | Sale 10b5-1 | −19,317 | $27.01 | $521,752 | 96,674 | D |
| Patel Sanj K CHAIRMAN & CEO | 2025-05-28 | Option exercise 10b5-1 | +62,116 | $1.59 | $98,764 | 158,790 | D |
| Patel Sanj K CHAIRMAN & CEO | 2025-05-28 | Sale 10b5-1 | −62,116 | $27.33 | $1,697,630 | 96,674 | D |
| Derivatives | |||||||
| Patel Sanj K CHAIRMAN & CEO | 2025-05-23 | Option exercise · Share Option 10b5-1 | −4,837 | 81,433 | D | ||
| Patel Sanj K CHAIRMAN & CEO | 2025-05-27 | Option exercise · Share Option 10b5-1 | −19,317 | 62,116 | D | ||
| Patel Sanj K CHAIRMAN & CEO | 2025-05-28 | Option exercise · Share Option 10b5-1 | −62,116 | 0 | D | ||
| Open-market sales · 86,270 sh · avg $27.24 · $2,349,981 | |||||||
Loading xslF345X05/form4-05282025_050501.xml…